Loading…

L&K Biomed acquired land and a building to construct a new automated spinal implant factory in Seoul, South Korea. The company plans to double production capacity to KRW 200 billion annually by the first half of 2027.
“신공장 건설을 위한 이번 자산 매입은 그 동안 회사가 준비해오던 글로벌 공급망 확대 및 미래 신사업의 본격화를 알리는 신호탄이 될 것”ir.newspim.com
Summarized from public sources; check the original articles before acting on it.